Drugs should be considered potential culprits in patients who present with musculoskeletal disorders

Author： Adis International Limited  

Publisher： Adis International

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.23, Iss.10, 2007-10, pp. : 21-24

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Imatinib should be considered for patients with unresectable dermatofibrosarcoma protuberans

By  

Inpharma, Vol. 1, Iss. 1624, 2008-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Lifestyle Drugs: Determining Their Value and Who Should Pay

By Mitrany D.  

PharmacoEconomics, Vol. 19, Iss. 5, 2001-01 ,pp. : 441-448

Adis International

Access to resources Recommend Favorite

HMG CoA reductase inhibitor [statin] therapy should be considered for older patients

By  

Inpharma, Vol. 1, Iss. 1237, 2000-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Antiapoptotic potential of herbal drugs in cardiovascular disorders: An overview

By Ahmad Rahila   Javed Saleem   Bhandari Uma  

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 48, Iss. 4, 2010-04 ,pp. : 358-374

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Potential of Phytochemicals in Combination with Drugs for Cardiovascular Disorders

By  

Current Pharmaceutical Design, Vol. 23, Iss. 6, 2017-03 ,pp. : 961-966

Bentham Science Publishers

Access to resources Recommend Favorite